![]()
|
|
||||||||
J. Biol. Chem., Vol. 255, Issue 12, 5776-5788, 06, 1980
JJ McGuire, P Hsieh, JK Coward and JR Bertino
Rat liver folylpolyglutamate synthetase was partially purified and its
reaction and products were characterized. The preparation contained no
conjugase activity. Gel filtration analysis revealed a molecular weight of
69,000. The synthetase was optimally active at pH 8.4 (37 degrees C),
required mercaptoethanol and a monovalent cation, and was highly specific
for L-glutamate. Only purine nucleoside triphosphates served as the energy
source for the reaction; ATP and dATP gave the best activity. All naturally
occurring folates (including 5-methyl- tetrahydrofolic acid) as well as a
number of folate analogs (including methotrexate) served as substrates. The
unnatural diastereoisomer of at least one folate, 5,6,7,8-tetrahydrofolic
acid, was also a substrate. Modifications of the terminal, acceptor
glutamate led to loss of substrate activity, as well as loss of binding.
High pressure liquid chromatography analysis, conjugase digestion, double
radiolabel studies, and amino acid analysis of acid-hydrolyzed product
confirmed that folylpoly-gamma-glutamates were synthesized. High
concentrations of (dl)-5,6,7,8-tetrahydrofolic acid favored accumulation of
short chain (predominantly diglutamate) products while low concentrations
favored accumulation of longer chains (predominantly tetraglutamate). This
inverse relationship between concentration and chain length may be of
regulatory significance. Synthesis of pentaglutamate forms, the predominant
chain length of rat liver folates in vivo, was detected at low
(dl)-5,6,7,8-tetrahydrofolic acid, but hexaglutamate was not detected.
Synthetic (l)-5,6,7,8-tetrahydropteroylpentaglutamate was a poor substrate
for the synthetase but it inhibited formation of polyglutamates from
monoglutamates. These observations indicate that the predominant chain
length of folates in rat liver may be determined solely by the substrate
specificity of the rat liver synthetase. Inhibition by the specificity of
the rat liver synthetase. Inhibition by the pentaglutamate derivative
offers a means by which folylpolyglutamates could regulate their own
synthesis.
Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. Ifergan, A. Shafran, G. Jansen, J. H. Hooijberg, G. L. Scheffer, and Y. G. Assaraf Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression: A ROLE FOR BCRP IN CELLULAR FOLATE HOMEOSTASIS J. Biol. Chem., June 11, 2004; 279(24): 25527 - 25534. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sybesma, M. Starrenburg, L. Tijsseling, M. H. N. Hoefnagel, and J. Hugenholtz Effects of Cultivation Conditions on Folate Production by Lactic Acid Bacteria Appl. Envir. Microbiol., August 1, 2003; 69(8): 4542 - 4548. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-S. Chen, R. W. Robey, M. G. Belinsky, I. Shchaveleva, X.-Q. Ren, Y. Sugimoto, D. D. Ross, S. E. Bates, and G. D. Kruh Transport of Methotrexate, Methotrexate Polyglutamates, and 17{beta}-Estradiol 17-({beta}-D-glucuronide) by ABCG2: Effects of Acquired Mutations at R482 on Methotrexate Transport Cancer Res., July 15, 2003; 63(14): 4048 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M.J. van der Put, H. W.M. van Straaten, F. J.M. Trijbels, and H. J. Blom Folate, Homocysteine and Neural Tube Defects: An Overview Experimental Biology and Medicine, April 1, 2001; 226(4): 243 - 270. [Abstract] [Full Text] |
||||
![]() |
G. J. Leclerc and J. C. Barredo Folylpoly-{{gamma}}-glutamate Synthetase Gene mRNA Splice Variants and Protein Expression in Primary Human Leukemia Cells, Cell Lines, and Normal Human Tissues Clin. Cancer Res., April 1, 2001; 7(4): 942 - 951. [Abstract] [Full Text] |
||||
![]() |
E. L. Volk, K. Rohde, M. Rhee, J. J. McGuire, L. A. Doyle, D. D. Ross, and E. Schneider Methotrexate Cross-Resistance in a Mitoxantrone-selected Multidrug-resistant MCF7 Breast Cancer Cell Line Is Attributable to Enhanced Energy-dependent Drug Efflux Cancer Res., July 1, 2000; 60(13): 3514 - 3521. [Abstract] [Full Text] |
||||
![]() |
F. B. Turner, J. L. Andreassi II, J. Ferguson, S. Titus, A. Tse, S. M. Taylor, and R. G. Moran Tissue-specific Expression of Functional Isoforms of Mouse Folylpoly-{{gamma}}-glutamate Synthetase: A Basis for Targeting Folate Antimetabolites Cancer Res., December 1, 1999; 59(24): 6074 - 6079. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Barnes, E. J. Estlin, G. A. Taylor, G. W. Aherne, A. Hardcastle, J. J. McGuire, J. A. Calvete, J. Lunec, A. D. J. Pearson, and D. R. Newell Impact of Polyglutamation on Sensitivity to Raltitrexed and Methotrexate in Relation to Drug-induced Inhibition of de Novo Thymidylate and Purine Biosynthesis in CCRF-CEM Cell Lines Clin. Cancer Res., September 1, 1999; 5(9): 2548 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Sirotnak Enhancing Cytotoxic Sensitivity of Tumor Cells to Antifolates: Another Opportunity for Gene Therapy? J Natl Cancer Inst, July 21, 1999; 91(14): 1178 - 1179. [Full Text] [PDF] |
||||
![]() |
K. Roy, M. G. Egan, S. Sirlin, and F. M. Sirotnak Posttranscriptionally Mediated Decreases in Folylpolyglutamate Synthetase Gene Expression in Some Folate Analogue-resistant Variants of the L1210 Cell. EVIDENCE FOR AN ALTERED COGNATE mRNA IN THE VARIANTS AFFECTING THE RATE OF DE NOVO SYNTHESIS OF THE ENZYME J. Biol. Chem., March 14, 1997; 272(11): 6903 - 6908. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Roy, K. Mitsugi, and F. M. Sirotnak Additional Organizational Features of the Murine Folylpolyglutamate Synthetase Gene. TWO REMOTELY SITUATED EXONS ENCODING AN ALTERNATE 5prime END AND PROXIMAL OPEN READING FRAME UNDER THE CONTROL OF A SECOND PROMOTER J. Biol. Chem., February 28, 1997; 272(9): 5587 - 5593. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Roy, K. Mitsugi, and F. M. Sirotnak Organization and Alternate Splicing of the Murine Folylpolyglutamate Synthetase Gene. DIFFERENT SPLICE VARIANTS IN L1210 CELLS ENCODE MITOCHONDRIAL OR CYTOSOLIC FORMS OF THE ENZYME J. Biol. Chem., September 27, 1996; 271(39): 23820 - 23827. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, H. Qi, J. Korenberg, T. A. Garrow, Y.-J. Choi, and B. Shane Purification and Properties of Human Cytosolic Folylpoly-gamma -glutamate Synthetase and Organization, Localization, and Differential Splicing of Its Gene J. Biol. Chem., May 31, 1996; 271(22): 13077 - 13087. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Roy, K. Mitsugi, S. Sirlin, B. Shane, and F. M. Sirotnak Different Antifolate-resistant L1210 Cell Variants with either Increased or Decreased Folylpolyglutamate Synthetase Gene Expression at the Level of mRNA Transcription J. Biol. Chem., November 10, 1995; 270(45): 26918 - 26922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |